Placental fas/fas ligand expression in early pregnancy losses

American Journal of Reproductive Immunology

Volumn 60, Issue 1, 2008, Pages 1-7

  Guvendag Guven, Emine Seda ^a   Okur, Hamza ^b   Beksac, Mehmet Sinan ^b  

^a Maternity Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antiphospholipid antibody syndrome; Apoptosis; Factor V Leiden mutation; Fas; Fas ligand; Pregnancy loss

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; COLLAGENASE; FAS ANTIGEN; FAS LIGAND;

ADULT; ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPLANT; FEMALE; FETUS; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOGENESIS; INDUCED ABORTION; MISSED ABORTION; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SAFETY; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ANTIGENS, CD95; ANTIPHOSPHOLIPID SYNDROME; FACTOR V; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNE TOLERANCE; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 45349088064     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00583.x     Document Type: Article

References (32)

1. Hammer A, Blaschitz A, Daxbock C, Walcher W, Dohr G: Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy. Am J Reprod Immunol 1999; 41:41-51.
2. Aschkenazi S, Straszewski S, Verwer KM, Foellmer H, Rutherford T, Mor G: Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod 2002; 66:1853-1861.
3. Jerzak M, Bischof P: Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling. Eur J Obstet Gynecol Reprod Biol 2002; 100:138-142.
4. Mu J, Kanzaki T, Si X, Tomimatsu T, Fukuda H, Shioji M, Murata Y, Sugimoto Y, Ichikawa A: Apoptosis and related proteins in placenta of intrauterine fetal death in prostaglandin f receptor-deficient mice. Biol Reprod 2003; 68:1968-1974.
5. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA: Placental apoptosis in preeclampsia. Obstet Gynecol 2000; 96:271-276.
6. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY, Baek KH: Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev 2003; 66:24-31.
7. Bryant-Greenwood GD: The extracellular matrix of the human fetal membranes: Structure and function. Placenta 1998; 19:1-11.
8. Kokawa K, Shikone T, Nakano R: Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta 1998; 19:21-26.
9. Parry S, Strauss JF III: Premature rupture of the fetal membranes. N Engl J Med 1998; 338:663-670.
10. Payne SG, Smith SC, Davidge ST, Baker PN, Guilbert LJ: Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis. Biol Reprod 1999; 60:1144-1150.
11. Hsu CD, Harirah H, Basherra H, Mor G: Serum soluble Fas levels in preeclampsia. Obstet Gynecol 2001; 97:530-532.
12. Pongcharoen S, Searle RF, Bulmer JN: Placental Fas and Fas ligand expression in normal early, term and molar pregnancy. Placenta 2004; 25:321-330.
13. Yacobi S, Ornoy A, Blumenfeld Z, Miller RK: Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratology 2002; 66:300-308.
14. Katsuragawa H, Rote NS, Inoue T, Narukawa S, Kanzaki H, Mori T: Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 172:1592-1597.
15. Krammer PH: CD95's deadly mission in the immune system. Nature 2000; 407:789-795.
16. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G: First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 2004; 10:55-63.
17. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS: Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997; 56:50-58.
18. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999; 42:1309-1311.
19. Riccardi C, Nicoletti I: Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1:1458-1461.
20. Costa Hde L, de Moura MD, Ferriani RA, Anceschi MI, Barbosa JE: Prevalence of anti-cardiolipin antibody in habitual aborters. Gynecol Obstet Invest 1993; 36:221-225.
21. Huppertz B, Tews DS, Kaufmann P: Apoptosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int Rev Cytol 2001; 205:215-253.
22. Halperin R, Peller S, Rotschild M, Bukovsky I, Schneider D: Placental apoptosis in normal and abnormal pregnancies. Gynecol Obstet Invest 2000; 50:84-87.
23. Kuntz TB, Christensen RD, Stegner J, Duff P, Koenig JM: Fas and Fas ligand expression in maternal blood and in umbilical cord blood in preeclampsia. Pediatr Res 2001; 50:743-749.
24. Eblen AC, Gercel-Taylor C, Shields LB, Sanfilippo JS, Nakajima ST, Taylor DD: Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil Steril 2000; 73:305-313.
25. Nayar R, Lage JM: Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature. Hum Pathol 1996; 27:201-206.
26. Nelson DM: Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996; 17:387-391.
27. Chan CC, Lao TT, Cheung AN: Apoptotic and proliferative activities in first trimester placentae. Placenta 1999; 20:223-227.
28. Farquharson RG, Quenby S, Greaves M: Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment. Obstet Gynecol 2002; 100:408-413.
29. Lockwood CJ: Inherited thrombophilias in Dregnant patients: detection and treatment paradigm. Obstet Gynecol 2002; 99:333-341.
30. Chaouat G, Clark DA: FAS/FAS ligand interaction at the placental interface is not required for the success of allogeneic pregnancy in anti-paternal MHC preimmunized mice. Am J Reprod Immunol 2001; 45:108-115.
31. Rogers AM, Boime I, Connolly J, Cook JR, Russell JH: Maternal-fetal tolerance is maintained despite transgene-driven trophoblast expression of MHC class I, and defects in Fas and its ligand. Eur J Immunol 1998; 28:3479-3487.
32. Kauma SW, Huff TF, Hayes N, Nilkaeo A: Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab 1999; 84:2188-2194.